MBNL1 and myotonic dystrophy type 2: Aberrant splicing, the misprocessing of RNA and proteins, and sequestration of transcription and splice modification molecules (e.g., muscleblind-like proteins (MBNL)) are key players in the pathophysiology of DM2.